|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT02528487 |
|
Date of registration:
|
17/08/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program?
|
|
Scientific title:
|
Predictors of the Long-term Functional Benefits of a Pulmonary Rehabilitation Program? |
|
Date of first enrolment:
|
May 2015 |
|
Target sample size:
|
360 |
|
Recruitment status: |
Suspended |
|
URL:
|
https://clinicaltrials.gov/show/NCT02528487 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Grégory Moullec, Ph.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hopital du Sacre-Coeur de Montreal |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Patients over the age of 40 will be eligible if
2. they are diagnosed with moderate-severe COPD,
3. currently participate to a PR program, and
4. agree to participate.
Exclusion Criteria:
They will be excluded if:
1. they have any comorbidity that is more important (i.e., more likely to cause morbidity
or mortality) than COPD (e.g., active cancer),
2. they have contraindications to exercise (though they will not likely be referred to
PR),
3. they have participated in a PR program in the past year,
4. and if they are unable to provide informed consent due to language difficulties or
cognitive impairment.
Age minimum:
40 Years
Age maximum:
90 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Obstructive Pulmonary Disease
|
|
Primary Outcome(s)
|
|
The change in exercise tolerance at 1-year post-PR
[Time Frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.]
|
|
Secondary Outcome(s)
|
|
The change in health-related quality of life (HRQoL) at 1-year post-PR
[Time Frame: Participants will be evaluated at 3 time points: (1) post-PR; (2) at 6-mo; (3) at 12-mo follow-up.]
|
|
Secondary ID(s)
|
|
2015-1132 (MP)
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|